Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Wesana Health Reports Q3 2021 Financial Results

Wesana Health Reports Q3 2021 Financial Results

  • Post published:November 29, 2021
  • Post category:Press Release
Read more about the article Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

  • Post published:November 19, 2021
  • Post category:Press Release
Read more about the article Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline

Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline

  • Post published:September 14, 2021
  • Post category:Press Release
Read more about the article Wesana Health Announces Closing of PsyTech Acquisition

Wesana Health Announces Closing of PsyTech Acquisition

  • Post published:September 9, 2021
  • Post category:Press Release
Read more about the article Distinguished Psychedelic Researcher, Professor of Psychiatry and Neuroscience, Rachel Yehuda, PhD, Joins Wesana Health Scientific Advisory Board

Distinguished Psychedelic Researcher, Professor of Psychiatry and Neuroscience, Rachel Yehuda, PhD, Joins Wesana Health Scientific Advisory Board

  • Post published:August 31, 2021
  • Post category:Press Release
Read more about the article Wesana Health Highlights Recent Appointments to Board of Directors

Wesana Health Highlights Recent Appointments to Board of Directors

  • Post published:August 19, 2021
  • Post category:Press Release
Read more about the article Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury

Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury

  • Post published:August 11, 2021
  • Post category:Press Release
Read more about the article Ian Burnstein Joins Wesana Health Advisory Board

Ian Burnstein Joins Wesana Health Advisory Board

  • Post published:July 14, 2021
  • Post category:Press Release
Read more about the article Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc.

Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc.

  • Post published:July 13, 2021
  • Post category:Press Release
Read more about the article Wesana Health Partners with University of South Carolina

Wesana Health Partners with University of South Carolina

  • Post published:June 24, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More